Cerapedics’ PearlMatrix P-15 peptide enhanced bone graft earned expanded FDA clearance for lumbar degenerative disc disease in adults.
The new clearance means PearlMatrix is the only Class III drug-device spinal bone graft approved for all major lumbar interbody surgical approaches, according to a Jan. 13 news release. It has indications for one-level ALIF, PLIF, OLIF, LLIF and TLIF.
PearlMatrix is also approved for use with itanium alloy and PEEK/titanium interbody fusion cages cleared by the FDA.
